A study for a 20 year old woman who takes Invega Sustenna - from FDA reports

314 females aged 20 (±5) who take the same drug are studied. This is a personalized study for a 20 year old female patient who has Schizophrenia. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).

On Aug, 16, 2018

314 females aged 20 (±5) who take Invega Sustenna are studied.

Number of reports submitted per year:

Invega Sustenna for a 20-year old woman.

Information of the patient in this study:

  • Age: 20
  • Gender: female
  • Conditions: Schizophrenia
  • Drugs taken:
    • Invega Sustenna (paliperidone palmitate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Galactorrhea (secretion of breast milk in men)
  2. Weight increased
  3. Injection site mass
  4. Depression
  5. Drug ineffective
1 - 6 months:
  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Application site pain
  3. Breast discharge
  4. Crying
  5. Blood prolactin increased
6 - 12 months:
  1. Hallucinations (sensations that appear real but are created by your mind)
  2. Weight increased
  3. Confusional state
  4. Stress and anxiety
  5. Head injury
1 - 2 years:
  1. Blood prolactin increased
  2. Suicidal ideation
  3. Menstruation irregular
  4. Negative thoughts
  5. Hypothalamo-pituitary disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function)
2 - 5 years:
  1. Psychotic disorder
5 - 10 years:
10+ years:
not specified:
  1. Galactorrhea (secretion of breast milk in men)
  2. Weight increased
  3. Blood prolactin increased
  4. Amenorrhea (absence of a menstrual period in a woman of reproductive age)
  5. Psychotic disorder

Top conditions involved for these people *:

  1. Bipolar Disorder (mood disorder): 37 people, 11.78%
  2. Psychotic Disorder : 20 people, 6.37%
  3. Stress And Anxiety : 9 people, 2.87%
  4. Depression : 8 people, 2.55%
  5. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 6 people, 1.91%

Top co-used drugs for these people *:

  1. Invega (28 people, 8.92%)
  2. Cogentin (12 people, 3.82%)
  3. Ativan (11 people, 3.50%)
  4. Klonopin (9 people, 2.87%)
  5. Risperdal (8 people, 2.55%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

Recent updates

General studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.